Barr today announced that it is challenging the patents protecting Aventis Pharmaceuticals, Inc.'s NASACORT(R) AQ (Triamcinolone Acetonide) Nasal Spray. Barr developed its Triamcinolone Acetonide ...

In terms of over-the-counter options, nasal steroids are the most effective single treatment for moderate to severe seasonal ...

Billing and Ordering TRIESENCE TRIESENCE (J3300 Injection, triamcinolone acetonide, preservative-free, 1 mg) is a single-use vial of 40 milligrams or 40 units based on the HCPCS descriptor.

Purpose: The stability of a triamcinolone acetonide mouthwash and its efficacy in treating oral lichen planus are described. Results: The mouthwash had a satisfactory shelf life and was well ...

Free naloxone nasal spray is offered in Ontario, Quebec, the Yukon and Northwest Territories. Unlike the more invasive injectable version, the overdose-reversing medication is sprayed directly ...

The Food and Drug Administration has turned away a proposed nasal spray from Milestone Pharmaceuticals to treat a type of irregular heartbeat over concerns about how the drug is manufactured.

Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a challenge for Milestone Pharmaceutical in its 22 years. Now the wait will ...